News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medigus (MDGS.TA) Announces Marketing Approval From the Israeli Ministry of Health (MEA) for SRS™ System for the Treatment of Gastroesophageal Reflux Disease (GERD)



9/12/2013 9:25:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OMER, Israel, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Medigus (MDGS.TA), a medical equipment company focused on the development and marketing of endoscopy-based medical procedures, announced today that it had received approval from the Israeli Ministry of Health for the registration of the SRS™ system for the treatment of Gastroesophageal Reflux Disease (GERD) in the Israeli Register of Medical Equipment and Accessories (MEA Approval). This approval follows FDA marketing clearance for the marketing and sales of the system in the United States, CE mark in Europe and approval for marketing in Canada from Health Canada, all of which had been attained earlier.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Medigus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES